Barrett's esophagus: proton pump inhibitors and chemoprevention II Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.

authors

  • Richter, Joel E
  • Penagini, Roberto
  • Pohl, Daniel
  • Dvorak, Katerina
  • Goldman, Aaron
  • Savarino, Edoardo
  • Zentilin, Patrizia
  • Savarino, Vincenzo
  • Watson, Joshua T
  • Wong, Roy KH
  • Pace, Fabio
  • Casini, Valentina
  • Peura, David A
  • Herzig, Shoshana Joy
  • Kamiya, Takeshi
  • Pelosini, Iva
  • Scarpignato, Carmelo
  • Armstrong, David
  • DeVault, Kenneth R
  • Bechi, Paolo
  • Taddei, Antonio
  • Freschi, Giancarlo
  • Ringressi, Maria Novella
  • Degli'Innocenti, Duccio Rossi
  • Castiglione, Francesca
  • Masini, Emmanuella
  • Hunt, Richard H

publication date

  • September 2011